Source: Markets Insider

BASi: Bioanalytical Systems, Inc., to Report First Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, February 9, 2021

WEST LAFAYETTE, Ind., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the "Company", "We", "Our" or "Inotiv"), doin...

Read full article »

BASi's Competitors | BASi's News | BASi's Financials

Followers on Owler

512

Est. Annual Revenue

$25-100M

Est. Employees

100-250

President & CEO

Robert Leasure, Jr.

CEO Approval Rating

85/100

BASi is an Indiana-based contract research organization that provides services such as drug discovery, bioanalytical method development and sample analysis.